Concepedia

Author

Juliette Soret‐Dulphy

Université Paris Cité

Also Known As

J. Soret-Dulphy, J. Soret‐Dulphy, Juliette Soret-Dulphy, Juliette Soret‐Dulphy

31

Publications

315

Citations

9

H-Index

10

Concepts

All Affiliations

Université Paris CitéAssistance Publique – Hôpitaux de ParisInsermHôpital Saint-LouisDélégation Paris 7
JS

About

Juliette Soret‐Dulphy is an author at Université Paris Cité specializing in cardiovascular disease, thrombosis, and molecular diagnostics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

26

2

Public Health

1

1

26

3

Epidemiology

1

1

26

4

Pathology

1

1

26

5

Hematology

1

1

26

Juliette Soret‐Dulphy

×

8

Publications

262

Citations

8

H-Index

YearCitations

Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo

Emmanuelle Verger, Juliette Soret‐Dulphy, Nabih Maslah,

Blood Cancer Journal

2018

51

Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses

Pierre-Édouard Debureaux, Bruno Cassinat, Juliette Soret‐Dulphy,

Blood Advances

2020

44

Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms

Clémence Marcault, Lin‐Pierre Zhao, Nabih Maslah,

Blood

2021

37

Interferon-Alpha (IFN) Therapy Discontinuation Is Feasible in Myeloproliferative Neoplasm (MPN) Patients with Complete Hematological Remission

Rafael Daltro De Oliveira, Juliette Soret‐Dulphy, Lin-Pierre Zhao,

Blood

2020

34

French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes

Matthieu Groh, Julien Rohmer, Nicolas Etienne,

Orphanet Journal of Rare Diseases

2023

34

Ruxopeg, a Multi-Center Bayesian Phase 1/2 Adaptive Randomized Trial of the Combination of Ruxolitinib and Pegylated Interferon Alpha 2a in Patients with Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis

Jean‐Jacques Kiladjian, Juliette Soret‐Dulphy, Matthieu Resche‐Rigon,

Blood

2018

26

Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification

Hélène Pasquer, Rafael Daltro De Oliveira, Loïc Vasseur,

Leukemia

2023

26

Hematological Response to Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: Application of a Novel Classification to Identify Unmet Clinical Needs and Future Clinical Goals

Pierre-Édouard Debureaux, Fabiana Cacace, Bruno G. P. Silva,

Blood

2019

10

Page 1